Lam Research Corporation $LRCX Shares Purchased by Advisors Asset Management Inc.

Advisors Asset Management Inc. boosted its stake in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 13.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 85,247 shares of the semiconductor company’s stock after purchasing an additional 10,348 shares during the period. Advisors Asset Management Inc.’s holdings in Lam Research were worth $11,415,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the second quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research in the second quarter valued at $27,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research during the 2nd quarter worth about $29,000. Delos Wealth Advisors LLC acquired a new stake in Lam Research during the 2nd quarter worth about $30,000. Finally, Bank of Jackson Hole Trust raised its stake in shares of Lam Research by 111.1% during the 2nd quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock valued at $37,000 after buying an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Multiple analyst upgrades and higher price targets reinforce upside expectations (Sanford C. Bernstein raised its target to $285; other outlets bumped targets to the mid‑$200s), supporting investor confidence. Bernstein Adjusts Price Target on Lam Research
  • Positive Sentiment: Industry and fundamentals view: commentary highlights strong AI/memory-driven demand, solid margins and $5B‑plus quarter potential — arguments used to justify a premium multiple. High P/E: Justified Premium or Too Pricey?
  • Neutral Sentiment: Technical signal: LRCX recently crossed above its 20‑day moving average, which can attract momentum traders but is a short‑term indicator. 20-Day Moving Average Crossover
  • Negative Sentiment: Insider selling: Director Eric Brandt sold 35,000 shares (~$7.9M), trimming his stake — a signal that can trigger short‑term investor caution even if not unusual for insiders to diversify. Director Sells 35,000 Shares
  • Negative Sentiment: Leadership/strategic concern: reporting on a leadership shift and the CEA‑Leti alliance prompted questions about whether recent multiple expansion is fully justified, creating valuation uncertainty for some investors. Leadership Shift And CEA Leti Alliance
  • Negative Sentiment: Options flow: unusually large put buying (roughly +112% vs. average) indicates elevated hedging or bearish positioning, which can amplify downside pressure in the near term.

Lam Research Stock Down 1.2%

Shares of NASDAQ:LRCX opened at $226.61 on Wednesday. The company has a market capitalization of $282.98 billion, a price-to-earnings ratio of 46.44, a PEG ratio of 2.46 and a beta of 1.78. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $251.87. The business has a 50-day moving average price of $197.23 and a 200 day moving average price of $152.89. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period last year, the business earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s payout ratio is currently 21.31%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Argus upped their price target on Lam Research from $175.00 to $280.00 in a report on Tuesday, February 3rd. Sanford C. Bernstein increased their target price on Lam Research from $275.00 to $285.00 and gave the company an “outperform” rating in a research report on Monday. Citigroup lifted their price target on shares of Lam Research from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a report on Thursday, January 29th. Finally, Mizuho set a $265.00 price objective on shares of Lam Research in a report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $244.88.

Read Our Latest Research Report on LRCX

Insider Activity

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.